90 Day Reset:   $750

Purpose: Deep Diagnostic Reset-Fast improvements and symptom relief.
We will address: 

*Diabetes risk, Cardiometabolic risk including GLP1 consideration, High visceral fat/low muscle mass and if relevant, Perimenopausal metabolic drift               

Labs: That support cardio and metabolic function as well as Thyroid and other endocrine and inflammatory markers.​

You can expect this cadence: 

Week 0–2         Full exam + baseline labs, Risk stratification and Target setting

Week 3–4         Lab review + intervention initiation

Weeks 4–8       Implementation phase (nutrition, training, meds if indicated)

Week 8              Checkpoint visit

Week 12             Targeted re-tests & Adjustments + next-step planning

Deliverable: 

Correct Metabolic Drift and Establish Objective Improvements.

Purpose: Risk reduction + metabolic performance stabilization + long-term longevity architecture

It addresses things like :ApoB trajectory, Insulin resistance, Body composition, Hormonal decline (if appropriate), Inflammation,Cardiovascular risk 

It is systems-level, not tactical.​

Phase 1: Advanced Risk Stratification (Month 0–1)

Includes: Expanded Diagnostics, Full baseline panel with strategic  reassessment and 6-month outcome comparison. 

We will create together a:

• Written Risk Reduction Blueprint

• Personalized 6-month target plan

Phase 2: Targeted Intervention (Months 2–4)

Review:

• Medication and HRT balance

• Structured protein intake and visceral fat levels

• Lipid lowering strategy (lifestyle ± pharmacologic)

Visits:  Monthly follow-ups. & Data and symptom review at each visit

Optional value differentiator:

• Mid-cycle insulin check and CGM second round (if used initially)

​Phase 3: Re-Test & ReCalibration (Month 5–6)

• Labs Repeated 

• Body composition and Overall symptom Review Head-to-Toe

Deliverables

• Before/After risk comparison and Long-term maintenance strategy

• Number of visits ( 6–8 total) with Secure messaging access

• Lab Review and Written Shared Planning

• Medication & Supplement protocol guidance

• Exercise direction framework​​-Commitment

This is for those

• Age 40–65

• Elevated ApoB or insulin resistance

• Early cardiometabolic risk

• Perimenopausal metabolic shift

• High performers preventing decline

The 12-Month Journey           $5000

is not just “more visits.”

It is trajectory control + aging mitigation + performance preservation.

It must feel like long-term strategic medical partnership.

The 12-month program is for:

• Clients with measurable cardiometabolic risk

• Perimenopausal / menopausal irregularities

• Those on GLP-1, HRT, lipid therapy, or multiple interventions

• Those ready for commitment, transparency, accountability & discipline

Structural Architecture

Phase 1: Comprehensive Baseline (Month 0–1)

Everything in the 6-month program plus:

• Deeper intervention into lab values, sleep, diet and exercise

• 12-Month Risk & Performance Blueprint

Phase 2: Active Optimization (Months 2–6)

• Medication stabilization/perhaps reduction

• Visits: Monthly or every 6 weeks

• Mid-cycle labs at Month 4–5:​

Phase 3: Advanced Stabilization (Months 7–9)

Now the focus shifts from correction → preservation.

• Measure Performance metrics 

• Further fine tune hormones and symptoms

• Sleep & recovery change 

• Body composition reassessment

This phase differentiates it from 6 months.

Phase 4: Year-End Reassessment (Months 10–12)

Full repeat panel of labs. Tight reviews of progress and symptom improvement

Deliverable:

• Year-over-year risk comparison

• Alter long-term aging trajectory through continuous strategic optimization.

• Executive Style Summary Report